Dr. Mark Schockaert - Huisarts, gespecialiseerd in de sportgeneeskunde.
0843.880.895 · rovalta.com · 28/09/2026
Dr. Mark Schockaert - Huisarts, gespecialiseerd in de sportgeneeskunde.
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBODr. Mark Schockaert - Huisarts, gespecialiseerd in de sportgeneeskunde. is a Private limited company incorporated in 2012. Its main activity is: General medical practice activities. Its registered office is in Lievegem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0843.880.895
- Incorporation
- 15/02/2012
- Legal form
- Private limited company
- Registered office
- Stationsstraat 78
9950 Lievegem · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 147,7 k € | -14.0% | 171,8 k € | -4.1% | 179,2 k € | +1.8% | 176 k € | +8.5% | 162,3 k € |
| EBITDA | 145,1 k € | -14.3% | 169,3 k € | -2.5% | 173,6 k € | -0.7% | 174,9 k € | +8.5% | 161,2 k € |
| Operating result | 122,5 k € | -16.4% | 146,6 k € | -4.5% | 153,5 k € | +0.4% | 152,8 k € | +27.9% | 119,5 k € |
| Net result | 93,5 k € | -11.8% | 106 k € | -2.5% | 108,7 k € | +2.6% | 106 k € | +29.8% | 81,7 k € |
| Balance sheet | |||||||||
| Equity | 908,8 k € | +11.5% | 815,3 k € | +14.9% | 709,3 k € | +18.1% | 600,5 k € | +21.4% | 494,5 k € |
| Total assets | 920 k € | +8.1% | 851,2 k € | +12.5% | 756,8 k € | +18.9% | 636,6 k € | +16.6% | 546 k € |
| Cash | 443 k € | +20.6% | 367,5 k € | +16.1% | 316,6 k € | +24.6% | 254 k € | +29.4% | 196,4 k € |
| Debts | 10,3 k € | -71.1% | 35,5 k € | -24.7% | 47,1 k € | +31.5% | 35,9 k € | -30.1% | 51,3 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Mark SCHOCKAERT | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/04/2026 | 05/05/2025 | 30/04/2024 | 28/04/2023 | 29/04/2022 | 10/05/2021 |
| General meeting | 31/03/2026 | 30/03/2025 | 31/03/2024 | 30/03/2023 | 28/03/2022 | 29/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 31/03/2026 | 30/04/2026 | Dutch | |
| Micro model | 30/09/2024 | 30/03/2025 | 05/05/2025 | Dutch | |
| Micro model | 30/09/2023 | 31/03/2024 | 30/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 30/03/2023 | 28/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 28/03/2022 | 29/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 29/03/2021 | 10/05/2021 | Dutch | |
| Micro model | 30/09/2019 | 06/04/2020 | 30/04/2020 | Dutch | |
| Micro model | 30/09/2018 | 21/03/2019 | 02/05/2019 | Dutch | |
| Micro model | 30/09/2017 | 22/03/2018 | 02/05/2018 | Dutch | |
| Abridged model | 30/09/2016 | 15/04/2017 | 03/05/2017 | Dutch | |
| Abridged model | 30/09/2015 | 14/03/2016 | 04/04/2016 | Dutch | |
| Abridged model | 30/09/2014 | 16/03/2015 | 27/03/2015 | Dutch | |
| Abridged model | 30/09/2013 | 29/03/2014 | 18/04/2014 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Mark SCHOCKAERT | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Stationsstraat 78, 9950 WaarschootCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00102695 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Mark Schockaert - Huisarts, gespecialiseerd in de sportgeneeskunde.Current | accounts 2021 → 2025 | Accounts 2025 · 2026-00102695 |
Events
- 2025Annual accounts 202593,5 k €↓
- 2024Annual accounts 2024106 k €↓
- 2023Annual accounts 2023108,7 k €↑
- 2022Annual accounts 2022106 k €↑
- 2021Annual accounts 202181,7 k €↑
- 2020Annual accounts 202065,1 k €↑
- 2019Annual accounts 201958,3 k €↓
- 2018Annual accounts 201884,3 k €↑
- 2017Annual accounts 201778,1 k €↑
- 2016Annual accounts 201649,8 k €↑
- 2015Annual accounts 201540,6 k €↑
- 2014Annual accounts 201411,6 k €↓
- 2013Annual accounts 201345,5 k €
- 15/02/2012IncorporationPrivate limited company